Background: We aimed to examine the acute effect of aliskiren on smoking-induced endothelial dysfunction in smoker.
Methods: Nineteen male smokers were enrolled. After all participants smoked a cigarette, their endothelial function was assessed with brachial artery flow mediated dilation (FMD). An hour after the administration of aliskiren, they smoked again, their FMD was assessed again. A month later, all measurements were performed again without the administration of aliskiren as a control. Blood pressure, plasma renin activity, and serum interleukin-6 concentration were also examined at the same time of FMD measurement.
Results: A cigarette smoking led to an acute endothelial dysfunction (6.5 ± 1.7% to 3.4 ± 1.0 %, P = 0.02). Aliskiren administration significantly suppressed blood pressure and plasma renin activity, furthermore, improved FMD (6.7 ± 0.5% to 8.1 ± 0.8 %, P = 0.03). Aliskiren significantly reduced serum interleukin-6 concentration, but not in control.
Conclusion: Aliskiren has a beneficial effect on smoking-induced acute endothelial dysfunction.
Published on: Oct 27, 2014 Pages: 38-41
Columbia University, USA
Journal of Novel Physiotherapy and Physical Rehabilitation
University of Athens , Greece
International Journal of Oral and Craniofacial Science
Malgorzata Gabriela WASNIEWSKA
University of Messina, Italy
International Journal of Clinical Endocrinology and Metabolism
University of Parma, Italy
International Journal of Dermatology and Clinical Research
Metaxas Memorial Anticancer Hospital , Greece
Annals of Bone Marrow Research